SNPMiner Trials (Home Page)
Report for SNP rs2293152
Developed by Shray Alag, 2020.
SNP Clinical Trial Gene
There is one clinical trial.
Clinical Trials
1 The Effectiveness of a Mediterranean Diet Intervention in NAFLD Clinical Course
The effects of Mediterranean Diet (MedDiet) on clinical, biochemical and inflammatory profile in NAFLD patients with simple steatosis. Potential associations of single nucleotide polymorphisms to diet composition and patients' profile were also investigated.
NCT03203486 NAFLD Steatosis of Liver Other: Mediterranean Diet MeSH:Non-alcoholic Fatty Liver Disease Fatty Liver
HPO:Hepatic steatosis
Furthermore, genotyping of STAT3 rs2293152 and GCKR rs1260326 single nucleotide polymorphisms takes place.
Primary Outcomes
Description: A decrease in liver fat
Measure: Regulation of hepatic steatosis Time: Change from Baseline to 6 monthsSecondary Outcomes
Description: Increase in MedDietScore
Measure: Adherence to MedDiet Time: Change from Baseline to 6 monthsDescription: Decrease in visfatin levels
Measure: Regulation of visfatin Time: Change from Baseline to 6 monthsDescription: Decrease in oxLDL levels
Measure: Regulation of oxLDL Time: Change from Baseline to 6 monthsDescription: Decrease in visfatin in carriers of the risk allele
Measure: Association of single nucleotide polymorphisms to response to dietary treatment Time: Change from Baseline to 6 months